Skip to main content
[Preprint]. 2021 Jan 4:2021.01.03.21249180. [Version 2] doi: 10.1101/2021.01.03.21249180

Figure 4. Asymptomatic and mildly symptomatic children do not display different antibody landscapes.

Figure 4.

Pediatric and adult samples were stratified according to the symptom score of the patients (asymptomatic « asympto » (pediatric COVID-19 n=98, adults COVID-19 n=9) versus symptomatic « sympto » (pediatric COVID-19 n=156, adults COVID n=27)), data from Figure 1 and 2 were analyzed according to “asympto” and “sympto”. (a) Antibodies against the SARS-CoV-2 structural proteins S1, S2, S2’, N, E, and M by LIPS. (b) Antibodies against SARS-COV-2 NSP1 (in ORF1ab), and all other ORFs (ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8 and ORF10). Two-sided P values were calculated using the Mann-Whitney U test. * shows statistical significance between COVID-19 patients versus negative controls. *p<0.05, **p<0.01, ***p<0.005, **** p<0,0001. All data represent individual responses and the mean +/− stdev.